Cytran Report issue

For profit Phase 2 Phase 3
Founded: Kirkland WA United States (1991)
Status: Defunct (2002)

Organization Overview

First Clinical Trial
1999
NCT00002445
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2001

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

Oglufanide (2 trials)

Drugs in Phase 2 Trials (2)

carboplatin (paraplatin) (1 trial)

paclitaxel (taxol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Ovarian Epithelial (Phase 2)

Ovarian Neoplasms (Phase 2)

Sarcoma (Phase 3)

Sarcoma, Kaposi (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3